These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34285885)

  • 1. Repurposing colchicine's journey in view of drug-to-drug interactions. A review.
    Vrachatis DA; Papathanasiou KA; Giotaki SG; Iliodromitis KE; Papaioannou TG; Stefanini GG; Cleman M; Siasos G; Reimers B; Lansky A; Tardif JC; Deftereos SG; Giannopoulos G
    Toxicol Rep; 2021; 8():1389-1393. PubMed ID: 34285885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine and plaque: A focus on atherosclerosis imaging.
    Aldana-Bitar J; Golub IS; Moore J; Krishnan S; Verghese D; Manubolu VS; Benzing T; Ichikawa K; Hamal S; Kianoush S; Anderson LR; Ramirez NR; Leipsic JA; Karlsberg RP; Budoff MJ
    Prog Cardiovasc Dis; 2024; 84():68-75. PubMed ID: 38423236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine in COVID-19: an Old Drug, New Use.
    Schlesinger N; Firestein BL; Brunetti L
    Curr Pharmacol Rep; 2020; 6(4):137-145. PubMed ID: 32837853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colchicine's Role in Cardiovascular Disease Management.
    Buckley LF; Libby P
    Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1031-1041. PubMed ID: 38511324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seeing Colchicine in a New Light: Repurposing Low-dose Colchicine for Secondary Prevention of Cardiovascular Disease.
    Nidorf SM
    Clin Ther; 2023 Nov; 45(11):1029-1033. PubMed ID: 37516564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine in Cardiovascular Disease: In-Depth Review.
    Deftereos SG; Beerkens FJ; Shah B; Giannopoulos G; Vrachatis DA; Giotaki SG; Siasos G; Nicolas J; Arnott C; Patel S; Parsons M; Tardif JC; Kovacic JC; Dangas GD
    Circulation; 2022 Jan; 145(1):61-78. PubMed ID: 34965168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
    Drosos AA; Pelechas E; Drossou V; Voulgari PV
    Rheumatol Ther; 2022 Apr; 9(2):379-389. PubMed ID: 35107804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Colchicine in Cardiovascular Diseases: A Systematic Review.
    Siak J; Flint N; Shmueli HG; Siegel RJ; Rader F
    Am J Med; 2021 Jun; 134(6):735-744.e1. PubMed ID: 33609528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Colchicine for the Prevention of Cardiovascular Events After Acute Coronary Syndrome.
    Gera P; Wasserstein DH; Frishman WH; Aronow WS
    Cardiol Rev; 2024 Jan; ():. PubMed ID: 38189365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Colchicine a New Game-Changer in Patients With Acute Coronary Syndrome?
    Nawabi AQ; Hassan W; Chen L; Shaikh N; Abbas K; Zehra FT
    Cureus; 2022 Mar; 14(3):e22874. PubMed ID: 35399435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine as a Novel Therapy for Suppressing Chemokine Production in Patients With an Acute Coronary Syndrome: A Pilot Study.
    Tucker B; Kurup R; Barraclough J; Henriquez R; Cartland S; Arnott C; Misra A; Martínez G; Kavurma M; Patel S
    Clin Ther; 2019 Oct; 41(10):2172-2181. PubMed ID: 31409556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of the Rational and Current Evidence on Colchicine for COVID-19.
    Ghaith HS; Gabra MD; Nafady MH; Elshawah HE; Negida A; Mushtaq G; Kamal MA
    Curr Pharm Des; 2022; 28(39):3194-3201. PubMed ID: 34895117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of Colchicine in preventing coronary vascular disease in childhood-onset lupus: a new view on an old drug.
    Abel D; Ardoin SP; Gorelik M
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):15. PubMed ID: 33593369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.
    Vrachatis DA; Papathanasiou KA; Giotaki SG; Raisakis K; Kossyvakis C; Kaoukis A; Kolokathis F; Deftereos G; Iliodromitis KE; Avramides D; Bogossian H; Siasos G; Giannopoulos G; Reimers B; Lansky A; Tardif JC; Deftereos S
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlocking Colchicine's Untapped Potential: A Paradigm Shift in Hepatocellular Carcinoma Prevention.
    Lin JJ; Lin CL; Chen CC; Lin YH; Cho DY; Chen X; Chen DC; Chen HY
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894398
    [No Abstract]   [Full Text] [Related]  

  • 18. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
    Krintus M; Kozinski M; Kubica J; Sypniewska G
    Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine poisoning: the dark side of an ancient drug.
    Finkelstein Y; Aks SE; Hutson JR; Juurlink DN; Nguyen P; Dubnov-Raz G; Pollak U; Koren G; Bentur Y
    Clin Toxicol (Phila); 2010 Jun; 48(5):407-14. PubMed ID: 20586571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine's other indication--effect of FDA action.
    Grody WW; Getzug T
    N Engl J Med; 2010 Dec; 363(23):2267-8. PubMed ID: 21121853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.